Renal artery stenosis is a disease where the arteries responsible for transporting blood to one or both of the kidneys become ...

The transaction is expected to be completed in the first half of 2025, subject to customary closing conditions.

These included two renal artery thromboses, one renal vein thrombosis and one superior mesenteric artery thrombosis. In subsequent animals, the addition of 100 units/kg heparin immediately before ...

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

Blood is transported to the kidney through the renal artery. The blood is filtered at a high pressure and the kidney selectively reabsorbs any useful materials such as glucose, salt ions and water.

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire SoniVie Ltd., ...

Boston Scientific will acquire SoniVie for up to $600 million on 100% basis, adding the TIVUS ultrasound system to its hypertension treatment pipeline. Deal closes in H1 2025.

Marlborough medical device manufacturer Boston Scientific has entered into a purchase agreement worth up to half a billion ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire SoniVie, a privately held medical device company that ...

Boston Scientific has reached an agreement to acquire SoniVie, a medical device company developing the TIVUS Intravascular Ultrasound System, an investigational technology aimed at treating ...